-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Bicycle Therapeutics Plc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
- Bicycle Therapeutics Plc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$767K, a 63.6% increase year-over-year.
- Bicycle Therapeutics Plc annual Deferred Income Tax Expense (Benefit) for 2023 was $3.31M.
- Bicycle Therapeutics Plc annual Deferred Income Tax Expense (Benefit) for 2022 was -$4.98M, a 198% decline from 2021.
- Bicycle Therapeutics Plc annual Deferred Income Tax Expense (Benefit) for 2021 was -$1.67M, a 148% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)